Identification of pathogenic T cells in patients with beryllium-induced lung disease

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 1019-1026

  Fontenot, Andrew P ^a,b   Falta, Michael T ^a,b   Freed, Brian M ^a   Newman, Lee S ^a,b   Kotzin, Brian L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM;

AMINO ACID SEQUENCE; ARTICLE; BERYLLIOSIS; EXPOSURE; GENE EXPRESSION; GRANULOMATOUS INFLAMMATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LUNG BIOPSY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; UNINDEXED SEQUENCE;

EID: 0033565395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Newman, L. S., L. A. Maier, and B. Nemery. 1998. Interstitial lung disorders due to beryllium and cobalt. In Interstitial Lung Disease. M. I. Schwarz, and T. E. King, Jr, eds. B.C. Decker Inc., Hamilton, p. 367.
2. Cullen, M. R., M. Ohrn, and J. R. Kominsky. 1986. Chronic beryllium disease in the United States. Sem. Respir. Med. 7:203.
3. Kreiss, K., L. S. Newman, M. Mroz, and P. A. Campbell. 1989. Screening blood test identifies subclinical beryllium disease. J. Occup. Med. 31:603.
4. Kreiss, K., S. Wasserman, M. M. Mroz, and L. S. Newman. 1993. Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations. J. Occup. Med. 35:267.
5. Kreiss, K., M. M. Mroz, B. Zhen, J. W. Martyny, and L. S. Newman. 1993. Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis. 148:985.
6. 3. Am. J. Ind. Med. 30:16.
7. Newman, L. S., C. Bobka, B. Schumacher, E. Daniloff, B. Zhen, M. Mroz, and T. E. King, Jr. 1994. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150:135.
8. Rossman, M. D., J. A. Kern, J. A. Elais, M. R. Cullen, P. E. Epstein, O. P. Preuss, T. N. Markham, and R. P. Daniele. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann. Intern. Med. 108:687.
9. Saltini, C., K. Winestock, M. Kirby, P. Pinkston, and R. G. Crystal. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med. 320:1103.
10. Fontenot, A. P., B. L. Kotzin, C. Comment, and L. S. Newman. 1998. Expansions of T-cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease. Am. J. Respir. Cell Mol. Biol. 18:581.
11. Epstein, P. E., J. H. Dauber, M. D. Rossman, and R. P. Daniele. 1982. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann. Intern. Med. 97:213.
12. Mroz, M. M., K. Kreiss, D. C. Lezotte, P. A. Campbell, and L. S. Newman. 1991. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54.
13. Newman, L. S., K. Kreiss, T. E. King, Jr., S. Seay, and P. A. Campbell. 1989. Pathologic and immunologic alterations in early stages of beryllium disease: reexamination of disease definition and natural history. Am. Rev. Respir. Dis. 139: 1479.
14. The BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am. Rev. Respir. Dis. 141:S168.
15. Calaman, S. D., G. R. Carson, L. D. Henry, J. S. Kubinec, R. E. Kuestner, A. Ahmed, E. M. Wilson, A. Y. Lin, C. W. Ritterhaus, and H. C. Marsh, Jr. 1993. Characterization of monoclonal antibodies specific for the Vβ3 family of the T cell receptor generated using soluble TCR β-chain. J. Immunol. Methods 164: 233.
16. Donahue, J. P., N. S. Ricalton, C. E. Behrendt, C. Rittershaus, S. Calaman, P. Marrack, J. W. Kappler, and B. L. Kotzin. 1994. Genetic analysis of low Vβ3 expression in humans. J. Exp. Med. 179:1701.
17. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718.
18. Posnett, D, N., C. S. Vissinga, C. Pambuccian, S. Wei, M. A. Robinson, D. Kostyu, and P. Concannon. 1994. Level of human TCRBV3S1 (Vβ3) expression correlates with allelic polymorphism in the spacer region of the recombination signal sequence. J. Exp. Med. 179:1707.
19. Ricalton, N. S., X. Paliard, J. Kappler, P. Marrack, and B. L. Kotzin. 1996. Analysis of TcRBV expression in human populations for evidence of superantigen exposure. Immunologist 4:106.
20. Richeldi, L., R. Sorrentino, and C. Saltini. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242.
21. Richeldi, L., K. Kreiss, M. M. Mroz, B. Zhen, P. Tartoni, and C. Saltini. 1997. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am. J. Ind. Med. 32:337.
22. Saltini, C., M. Amicosante, A. Franchi, G. Lombardi, and L. Richeldi. 1998. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model. Eur. Respir. J. 12:1463.
23. Newman, L., and K. Kreiss. 1992. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferation response to beryllium. Am. Rev. Respir. Dis. 145:1212.
24. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Sarcoidosis. N. Engl. J. Med. 336:1224.
25. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.
26. Tinkle, S. S., L. A. Kittle, B. A. Schumacher, and L. S. Newman. 1997. Beryllium induces IL-2 and IFN-γ in berylliosis. J. Immunol. 158:518.
27. Newman, L. S., J. Lloyd, and E. Daniloff. 1996. The natural history of beryllium sensitization and chronic beryllium disease. Environ. Health Perspect. 104:S937.
28. Moller, D. R., K. Konishi, C. Saltini, M. Kirby, and R. G. Crystal. 1988. Bias toward use of a specific T cell receptor β-chain variable region in a subgroup of individuals with sarcoidosis. J. Clin. Invest. 82:1183.
29. Forman, J. D., J. T. Klein, R. F. Silver, M. C. Liu, B. M. Greenlee, and D. R. Moller. 1994. Selective activation and accumulation of oligoclonal Vβ-specific T cells in active pulmonary sarcoidosis. J. Clin. Invest. 94:1533.
30. Forrester, J. M., Y. Wang, N. Ricalton, J. E. Fitzgerald, J. Loveless, L. S. Newman, T. E. King, and B. L. Kotzin. 1994. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J. Immunol. 153:4291.
31. Dohi, M., K. Yamamoto, K. Masuko, Y. Ikeda, G. Matsuzaki, H. Sugiyama, M. Suko, H. Okudaira, Y. Mizushima, K. Nishioka, and K. Ito. 1994. Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. J. Immunol. 152:1983.
32. + T cell clones in the synovial fluid of patients with rheumatoid arthritis. J. Immunol. 161:4428.
33. Sinigaglia, F. 1994. The molecular basis of metal recognition by T cells. J. Invest. Dermatol. 102:398.
34. Sinigaglia, F., D. Scheidegger, G. Garotta, R. Scheffer, M. Pletscher, and A. Lanzavecchia. 1985. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J. Immunol. 135:3929.
35. Hemdan, E. S., Y.-J. Zhao, E. Sulkowski, and J. Porath. 1988. Surface topography of histidine residues: a facile probe by immobilized metal ion affinity chromatography. Proc. Natl. Acad. Sci. USA 86:1811.